Adaptimmune Therapeutics plc Share Price
Stocks
ADAPY
US00653A1079
Pharmaceuticals
OTC Markets Traded|
Market Closed -
OTC Markets
01:21:35 19/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.0225 USD | -2.17% |
|
-0.66% | -13.46% |
| 19/05 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 17/11 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
| Market Cap | 59.64L 52L 49.1L 44.59L 83.54L 57Cr 83.89L 5.88Cr 2.27Cr 29Cr 2.24Cr 2.19Cr 94Cr | P/E 2024 |
-1.8x | P/E 2025 | 0.33x |
|---|---|---|---|---|---|
| Enterprise Value | -59.05L -51.49L -48.62L -44.15L -82.72L -57Cr -83.07L -5.82Cr -2.25Cr -29Cr -2.22Cr -2.17Cr -93Cr | EV / Sales 2024 |
0.34x | EV / Sales 2025 | -0.84x |
| Free-Float |
14.03% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -2.17% | ||
| 1 week | -0.66% | ||
| 1 month | -12.45% | ||
| 3 months | -43.75% | ||
| 6 months | +25.00% | ||
| Current year | -13.46% |
| 1 week | 0.01 |  | 0.03 |
| 1 month | 0 | | 0.03 |
| Current year | 0 | | 0.05 |
| 1 year | 0 | | 0.28 |
| 3 years | 0 | | 2.05 |
| 5 years | 0 | | 5.95 |
| 10 years | 0 | | 14.62 |
| Manager | Title | Age | Since |
|---|---|---|---|
Christopher Hill
CEO | Chief Executive Officer | 46 | 14/11/2025 |
Juli P. Miller
IRC | Investor Relations Contact | - | 01/08/2016 |
Phil Bassett
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Lawrence Alleva
CHM | Chairman | 76 | 14/11/2025 |
Garry Menzel
BRD | Director/Board Member | 61 | 01/06/2023 |
Christopher Hill
BRD | Director/Board Member | 46 | 14/11/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/09/25 | Sell | Chief Financial Officer | 96,000 | 0.0060% | ||
| 28/08/25 | Sell | Compliance Officer | 2,07,000 | 0.0130% | ||
| 15/08/25 | NEA Management Co. LLC
| Sell | Company | 1,95,00,000 | 7.3571% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.17% | -0.66% | -85.94% | -96.96% | 59.64L | |
| -0.58% | +0.43% | +31.09% | -4.81% | 7.84TCr | |
| -2.55% | +6.99% | +505.27% | +47.92% | 6.15TCr | |
| -1.11% | +5.08% | -11.47% | -33.91% | 5.98TCr | |
| +0.14% | -1.20% | -11.64% | +24.21% | 4.65TCr | |
| -0.24% | +1.22% | +2.26% | +151.03% | 4.55TCr | |
| -1.62% | -0.76% | +49.85% | -14.92% | 3.18TCr | |
| -1.81% | +3.16% | +45.71% | +110.57% | 2.54TCr | |
| +0.47% | +3.26% | -0.77% | +142.41% | 2.14TCr | |
| +0.27% | +1.96% | +62.19% | +102.81% | 1.58TCr | |
| Average | -0.92% | +1.91% | +58.66% | +42.83% | 3.86TCr | |
| Weighted average by Cap. | -0.92% | +2.35% | +93.51% | +40.27% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 18Cr 16Cr 15Cr 13Cr 25Cr 1.71TCr 25Cr 175.59Cr 68Cr 868.53Cr 67Cr 65Cr 2.79TCr | 59.24L 51.66L 48.78L 44.29L 82.99L 57Cr 83.33L 5.84Cr 2.25Cr 29Cr 2.23Cr 2.18Cr 93Cr |
| Net income | -7.08Cr -6.17Cr -5.83Cr -5.29Cr -9.92Cr -679.5Cr -9.96Cr -70Cr -27Cr -345.47Cr -27Cr -26Cr -1.11TCr | 2.52Cr 2.2Cr 2.08Cr 1.88Cr 3.53Cr 241.86Cr 3.55Cr 25Cr 9.59Cr 122.97Cr 9.47Cr 9.26Cr 395.66Cr |
| Net Debt | -7.74Cr -6.75Cr -6.37Cr -5.79Cr -11Cr -742.65Cr -11Cr -76Cr -29Cr -377.58Cr -29Cr -28Cr -1.21TCr | -1.19Cr -1.03Cr -97.73L -88.74L -1.66Cr -113.89Cr -1.67Cr -12Cr -4.52Cr -58Cr -4.46Cr -4.36Cr -186.31Cr |
Employees
272
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/26/18 | $0.0225 | -2.17% | 86,462 |
| 17/26/17 | $0.0230 | -8.00% | 69,921 |
| 16/26/16 | $0.0250 | 0.00% | 2,42,213 |
| 15/26/15 | $0.0250 | +4.17% | 2,28,690 |
| 14/26/14 | $0.0240 | +5.96% | 1,87,980 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ADAPY Stock
Select your edition
All financial news and data tailored to specific country editions
